The insulin like growth factor-1 receptor (IGF-1R) as a drug target: novel approaches to cancer therapy

Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
Corinna Bähr, Bernd Groner

Abstract

The insulin-like growth factor 1 receptor (IGF-1R) is an important signaling molecule in cancer cells and plays an essential role in the establishment and maintenance of the transformed phenotype. Inhibition of IGF-1R signaling thus appears to be a promising strategy to interfere with the growth and survival of cancer cells. Different classes of molecules, e.g., antisense RNA, monoclonal antibodies and dominant negative IGF-1R gene variants, have been employed towards this aim. These agents have been able to reverse the transformed phenotype in several rodent and human cancer cell lines. The application of peptide aptamers specifically binding to the IGF-1R represents a novel approach to target IGF-1R signaling. The integration of peptide aptamers into targeted protein degradation vehicles and their transduction into cells allows the temporary elimination of the receptor protein. This review summarizes recently published data about inhibition of IGF-1R signaling and provides a perspective on upcoming possibilities.

References

Nov 30, 1987·Biochemical and Biophysical Research Communications·Q T RohlikS Jacobs
Apr 1, 1995·Endocrine Reviews·D LeRoithC T Roberts
Sep 14, 1995·Biochemical and Biophysical Research Communications·J L BurgaudR Baserga
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·C SellR Baserga
May 27, 1997·Proceedings of the National Academy of Sciences of the United States of America·F RininslandJ Ilan
Jul 1, 1997·Molecular and Cellular Biology·B ValentinisR Baserga
Feb 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·D J HiltonN A Nicola
Jul 17, 1998·Current Opinion in Chemical Biology·R ZutshiJ Chmielewski
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·J G ZhangM Baca
Jul 27, 1999·Science·T C NormanA W Murray
Feb 9, 2000·Trends in Pharmacological Sciences·S R Schwarze, S F Dowdy
Aug 29, 2000·Cellular and Molecular Life Sciences : CMLS·T E AdamsC W Ward
Aug 31, 2000·Annual Review of Biochemistry·S R Hubbard, J H Till
Dec 22, 2000·Biochemistry·G BlumA Levitzki
Apr 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D W AndrewsR D Aiken
Nov 6, 2001·Nature Structural Biology·S FavelyukisW T Miller
Apr 30, 2002·Gan to kagaku ryoho. Cancer & chemotherapy·Yutaka TokudaTomoo Tajima
Aug 13, 2002·Oncogene·C Wilson Xu, Zhijun Luo
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Katia ScotlandiPiero Picci
Jul 19, 2003·The Journal of Biological Chemistry·Galia BlumAlexander Levitzki
Sep 19, 2003·Journal of Cancer Research and Clinical Oncology·Claudia Buerger, Bernd Groner
Sep 23, 2003·Acta Crystallographica. Section D, Biological Crystallography·Sanjeev MunshiLawrence C Kuo
Nov 15, 2003·The Journal of Biological Chemistry·Deepali SachdevDouglas Yee

❮ Previous
Next ❯

Citations

Aug 12, 2009·International Journal of Colorectal Disease·Kamal YavariMohammad Hossein Babaei
Oct 5, 2013·Journal of the National Cancer Institute·Dong Hoon ShinHo-Young Lee
Aug 9, 2005·Expert Opinion on Therapeutic Targets·Renato Baserga
Aug 9, 2011·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Eddy HimpeRon Kooijman
Jul 18, 2009·Archives of Medical Research·Kamal YavariMohammad Hosein Babaei
Feb 3, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Satoko KojimaYuzo Furuya
Apr 20, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Ru-Xian LinSheng-Qi Wang
Nov 25, 2011·International Journal of Cancer. Journal International Du Cancer·Seung Hyun OhHo-Young Lee
Feb 8, 2005·Trends in Molecular Medicine·Athanasios G PapatsorisAthanasios G Papavassiliou
Dec 1, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yoon-Jin LeeChoon-Taek Lee
Apr 19, 2005·European Journal of Internal Medicine·R A BadawiL Kalra
Dec 15, 2010·International Immunopharmacology·Shanrong ShuJing Wan
Oct 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Morteza MotallebnezhadMehdi Yousefi
Feb 19, 2019·Signal Transduction and Targeted Therapy·Man LuJo K Perry
Oct 4, 2017·Endocrine Reviews·Antonino BelfioreRiccardo Vigneri
Sep 9, 2008·Journal of Cellular and Molecular Medicine·Maarten F BijlsmaC Arnold Spek
Mar 6, 2019·International Journal of Molecular Sciences·Yoon-Mi LeeJi-Hong Lim
Apr 7, 2009·PloS One·Ekaterina MorozInna Serganova
Dec 25, 2010·Veterinary Ophthalmology·Alan L Weiner, Brian C Gilger
Oct 12, 2011·Basic & Clinical Pharmacology & Toxicology·Alessandra Milesi-HalléLaura P James
May 8, 2013·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Ke ZhuGuozhi Xiao
May 7, 2014·Veterinary Ophthalmology·Laura BarachettiBrian C Gilger
Sep 1, 2019·International Journal of Molecular Sciences·Synnøve Nymark AasenFrits Thorsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Nature Reviews. Cancer
Michael PollakSusan E Hankinson
International Journal of Cancer. Journal International Du Cancer
R BasergaKrysztof Reiss
Nature Reviews. Drug Discovery
Pierre De Meyts, Jonathan Whittaker
© 2022 Meta ULC. All rights reserved